Melqart 13F holdings, Q4 2019
Holdings as of December 31, 2019 · filings on SEC EDGAR · latest filing →
Melqart disclosed 36 US equity positions worth $1.1bn in its Q4 2019 13F filing. The largest position was ALLERGAN PLC at 11.8% of the reported book, followed by NXPI and CYPRESS SEMICONDUCTOR CORP. Against the Q3 2019 filing, it opened 19 new positions, added to 3 and reduced 9 among the top 36 holdings.
What did Melqart own in Q4 2019? Top 36 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q3 2019 |
|---|---|---|---|---|---|---|---|
| 1 | ALLERGAN PLC | 11.8% | $134.6m | 704,000 | 16% | added | |
| 2 | NXPI NXP SEMICONDUCTORS N V | Technology | 8.5% | $97.3m | 764,935 | -27% | reduced |
| 3 | CYPRESS SEMICONDUCTOR CORP | 7.0% | $79.6m | 3,413,000 | -11% | reduced | |
| 4 | ZAYO GROUP HLDGS INC | 6.7% | $76.3m | 2,201,000 | 0% | held | |
| 5 | IAC INTERACTIVECORP | 5.8% | $66.9m | 268,462 | – | new | |
| 6 | MELLANOX TECHNOLOGIES LTD | 5.6% | $64.1m | 547,088 | -13% | reduced | |
| 7 | VRTX VERTEX PHARMACEUTICALS INC | Healthcare | 5.5% | $63.0m | 287,900 | 80% | added |
| 8 | WABCO HLDGS INC | 4.5% | $51.9m | 383,000 | 0% | held | |
| 9 | TIFFANY & CO NEW | 4.1% | $47.0m | 351,500 | – | new | |
| 10 | WRIGHT MED GROUP N V | 3.6% | $41.7m | 1,369,000 | – | new | |
| 11 | AVAYA HLDGS CORP | 3.6% | $41.2m | 3,050,000 | -13% | reduced | |
| 12 | INTERXION HOLDING N.V | 3.5% | $40.2m | 480,000 | – | new | |
| 13 | LOGMEIN INC | 3.0% | $34.9m | 406,750 | – | new | |
| 14 | HGV HILTON GRAND VACATIONS INC | Consumer Cyclical | 2.9% | $32.8m | 954,200 | – | new |
| 15 | TAK TAKEDA PHARMACEUTICAL CO LTD | Healthcare | 2.7% | $30.7m | 1,557,000 | -7% | reduced |
| 16 | TECH DATA CORP | 2.3% | $26.6m | 185,000 | – | new | |
| 17 | INSTRUCTURE INC | 1.8% | $20.8m | 431,660 | – | new | |
| 18 | QIW QIWI PLC | 1.8% | $20.6m | 1,066,026 | 4% | added | |
| 19 | MEDICINES CO | 1.8% | $20.3m | 239,000 | – | new | |
| 20 | CISION LTD | 1.7% | $19.7m | 1,975,000 | – | new | |
| 21 | ASND ASCENDIS PHARMA A S | Healthcare | 1.4% | $16.1m | 115,404 | – | new |
| 22 | RNG RINGCENTRAL INC | Technology | 1.1% | $12.6m | 74,413 | -28% | reduced |
| 23 | QGEN QIAGEN NV | Healthcare | 1.1% | $12.5m | 370,600 | – | new |
| 24 | TEAM ATLASSIAN CORP PLC | Technology | 1.1% | $12.4m | 103,000 | -4% | reduced |
| 25 | TWLO TWILIO INC | Technology | 1.0% | $11.8m | 120,000 | 0% | held |
| 26 | CLF CLEVELAND CLIFFS INC | Basic Materials | 1.0% | $11.5m | 1,382,550 | – | new |
| 27 | FTCHQ FARFETCH LTD | Consumer Cyclical | 1.0% | $11.3m | 1,089,000 | – | new |
| 28 | FITBIT INC | 0.9% | $9.8m | 1,484,385 | – | new | |
| 29 | QUINTANA ENERGY SVCS INC | 0.8% | $9.2m | 3,288,449 | 0% | held | |
| 30 | ARQULE INC | 0.6% | $7.4m | 369,646 | – | new | |
| 31 | BRISTOL MYERS SQUIBB CO | 0.5% | $5.4m | 1,799,100 | – | new | |
| 32 | FIVN FIVE9 INC | Technology | 0.4% | $4.5m | 69,000 | -40% | reduced |
| 33 | INTELSAT S A | 0.3% | $3.9m | 560,403 | – | new | |
| 34 | AVAYA HLDGS CORP | 0.2% | $2.3m | 2,600,000 | 0% | held | |
| 35 | CYRUSONE INC | 0.2% | $2.3m | 34,782 | -91% | reduced | |
| 36 | AUDENTES THERAPEUTICS INC | 0.1% | $1.1m | 17,900 | – | new |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.